Leprosy Nursing Care
On this page
Direct answer
India eliminated leprosy as a public health problem in December 2005 (prevalence below 1 per 10,000) yet still accounts for a majority of the world's new cases, so nursing under the National Leprosy Eradication Programme (NLEP) remains examinable reality. Management is multidrug therapy (MDT), free: paucibacillary disease for 6 months with rifampicin and dapsone, multibacillary for 12 months with rifampicin, clofazimine and dapsone — with clofazimine now being added to the paucibacillary regimen in the programme's recent revisions. The two emergencies are the reactions: type 1 (reversal) with neuritis threatens irreversible nerve damage and needs urgent corticosteroids; type 2 (erythema nodosum leprosum) needs anti-inflammatory management — while disability prevention and anti-stigma counselling carry equal weight with the drugs.
What you must remember
- Classification: paucibacillary — up to 5 lesions, smear negative; multibacillary — more than 5 lesions or smear positive; diagnosed on the cardinal signs (anaesthetic hypopigmented patch, thickened nerve, positive smear).
- MDT durations: PB 6 months, MB 12 months — completed courses cure; the disease is only mildly infectious (prolonged close contact; rifampicin rapidly renders patients non-infectious), so isolation is never required.
- Drug counselling: dapsone — haemolysis and hypersensitivity warned of; clofazimine — reversible discolouration explained before it happens, or patients abandon treatment; monthly supervised rifampicin with daily companions.
- Type 1 (reversal) reaction: existing lesions become red, swollen and tender, with neuritis — nerve tenderness, new weakness or sensory loss in the distribution of a thickened nerve (commonly ulnar, median, posterior tibial); an emergency because prompt steroids prevent permanent paralysis and clawing.
- Type 2 reaction (erythema nodosum leprosum): crops of tender nodules with fever during MB treatment — managed with anti-inflammatories and clofazimine, while MDT continues.
- Disability prevention: daily mirror inspection of anaesthetic hands and feet, soaking and oiling, protective footwear (microcellular rubber soles), early wound reporting, and exercises and splinting — with WHO disability grading recorded.
- Stigma work: counselling that MDT cures, that deformity is preventable with early treatment, and that isolation imagery is obsolete — plus contact examination.
A patch that began to burn, and the nerve that was saved
A man under treatment for multibacillary leprosy returns because his forearm patch has become red, swollen and painful, and his hand feels weaker over two weeks. The triage recognises type 1 reaction with neuritis — treated with the urgency of a compartment syndrome, because inflamed nerves die quietly: ulnar groove tenderness documented, grip and intrinsic strength tested, sensory testing done, immediate referral for corticosteroids rather than "come back if worse". Weeks of supervised steroids preserve the hand a delay would have clawed.
His ongoing nursing is the rest of the programme: MDT completed despite the patch quieting at month three — unfinished MB courses are the classic relapse pathway — clofazimine discolouration explained before it appeared, and the self-care contract around his anaesthetic feet: nightly soaking, mirror inspection, microcellular footwear, and hot or sharp hazards assumed unrecognised. The household is examined and educated plainly: the disease needs prolonged close contact, the first rifampicin dose ends contagiousness, treatment is free, and the dreaded deformities are what untreated delay causes. Contrast the MB patient with tender nodules and fever — erythema nodosum leprosum, never a reason to stop MDT.
Where students slip
The durations are the bedrock question and the commonest slip — 6 and 12 months for PB and MB, with candidates inverting them or hedging into "until lesions resolve". The reaction pair is the discriminator: type 1 is the cell-mediated flare of existing lesions with emergency neuritis; type 2 is the nodules-with-fever of multibacillary disease — and the examined reflex is that new nerve weakness during treatment is referred today, because early steroids stand between the patient and a clawed hand. Clofazimine discolouration is the counselling favourite: pre-explained it retains patients; unexplained it loses them to default. And the isolation myth remains the reliable fail-and-pass item: no isolation, no infectivity after early treatment, and "cured" applied honestly to completed MDT.
Frequently asked questions
How long are paucibacillary and multibacillary MDT courses?
Paucibacillary disease is treated for 6 months and multibacillary for 12 months with the respective drug combinations — completed courses are curative.
Why is a type 1 leprosy reaction an emergency?
Because it causes neuritis — tender, thickened nerves with new weakness — that becomes irreversible within days to weeks without prompt corticosteroids.
How is a type 2 reaction (erythema nodosum leprosum) recognised?
Crops of tender red nodules with fever and systemic upset in a multibacillary patient on treatment — managed with anti-inflammatory regimens while continuing MDT.
What self-care do anaesthetic hands and feet require?
Daily inspection with a mirror, soaking and oiling, careful nail care, protective or microcellular rubber footwear, and immediate reporting of any wound — because unfelt injuries are the path to ulcers and deformity.
Is isolation or special precaution needed for a leprosy patient?
No — leprosy is only mildly infectious, requires prolonged close contact, and the first rifampicin dose rapidly eliminates infectivity; MDT is free and completed on an outpatient basis.